| Mechanical Circulatory Support Devices | Lifetime | 1 | DE 1 | 99.94 |
| Cardiac Structural Anomalies and Repair | Lifetime | 3 | DE 1 | 99.95 |
| Cardiac Arrest and Resuscitation | Lifetime | 11 | DE 2 | 99.90 |
| Cardiac Imaging and Diagnostics | Lifetime | 66 | DE 5 | 99.86 |
| Acute Myocardial Infarction Research | Lifetime | 51 | DE 4 | 99.81 |
| Cardiac Valve Diseases and Treatments | Lifetime | 116 | DE 12 | 99.71 |
| Cardiovascular Function and Risk Factors | Lifetime | 212 | DE 9 | 99.58 |
| Coronary Interventions and Diagnostics | Lifetime | 128 | DE 9 | 99.59 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 156 | DE 17 | 99.29 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 31 | DE 6 | 97.72 |
| COVID-19 and healthcare impacts | Lifetime | 303 | DE 6 | 95.97 |
| Advanced MRI Techniques and Applications | Lifetime | 910 | DE 87 | 98.03 |
| Cardiac and Coronary Surgery Techniques | Lifetime | 262 | DE 22 | 97.53 |
| Heart Failure Treatment and Management | Lifetime | 578 | DE 30 | 97.93 |
| Pericarditis and Cardiac Tamponade | Lifetime | 117 | DE 10 | 96.68 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 1 | DE 1 | 99.98 |
| Mechanical Circulatory Support Devices | 2021-2025 | 1 | DE 1 | 99.96 |
| Cardiac Arrest and Resuscitation | 2021-2025 | 3 | DE 1 | 99.91 |
| Acute Myocardial Infarction Research | 2021-2025 | 12 | DE 1 | 99.66 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 38 | DE 9 | 99.70 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 48 | DE 2 | 99.48 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 108 | DE 8 | 99.22 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 59 | DE 11 | 99.22 |
| Heart Failure Treatment and Management | 2021-2025 | 149 | DE 11 | 98.20 |
| Coronary Interventions and Diagnostics | 2021-2025 | 165 | DE 5 | 97.90 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 252 | DE 21 | 96.97 |
| COVID-19 and healthcare impacts | 2021-2025 | 460 | DE 13 | 93.32 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 752 | DE 68 | 94.98 |
| Aortic Disease and Treatment Approaches | 2021-2025 | 522 | DE 55 | 91.90 |
| Cardiac Health and Mental Health | 2021-2025 | 553 | DE 17 | 86.80 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 117 | DE 13 | 80.72 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 627 | DE 35 | 79.49 |
| Medical Practices and Rehabilitation | 2021-2025 | 92 | DE 83 | 75.10 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 941 | DE 24 | 74.94 |
| Healthcare cost, quality, practices | 2021-2025 | 679 | DE 23 | 74.66 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 803 | DE 48 | 54.64 |
| Nitric Oxide and Endothelin Effects | 2021-2025 | 801 | DE 43 | 55.59 |
